These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14335472)

  • 1. [THE EFFECT OF DESFERRIOXAMINE-B (DESFERAL) ON THE PLASMA CLEARANCE OF FE 59 IN HEALTHY PERSONS AND PATIENTS WITH PRIMARY HEMOCHROMATOSIS].
    OECHSLIN RJ; SCHMID JR
    Helv Med Acta; 1964 Nov; 31():604-9. PubMed ID: 14335472
    [No Abstract]   [Full Text] [Related]  

  • 2. [HEPATIC UPTAKE OF RADIOACTIVE IRON BEFORE AND AFTER ADMINISTRATION OF DESFERRIOXAMINE IN HEMOCHROMATOSIS].
    TRINCAO M; SERRAESILVA P
    J Soc Cienc Med Lisb; 1964 Feb; 128():110-5. PubMed ID: 14153536
    [No Abstract]   [Full Text] [Related]  

  • 3. IRON CHELATION WITH DEFEROXAMINE IN HEPATIC DISEASE.
    WALSH JR; MASS RE; SMITH FW; LANGE V
    Gastroenterology; 1965 Aug; 49():134-40. PubMed ID: 14323723
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES ON DESFERRIOXAMINE IN RELATION TO THE ABSORPTION OF IRON.
    BANNERMAN RM; MALPAS JS
    Br J Haematol; 1965 Jan; 11():15-20. PubMed ID: 14252103
    [No Abstract]   [Full Text] [Related]  

  • 5. DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
    FIELDING J
    J Clin Pathol; 1965 Jan; 18(1):88-97. PubMed ID: 14247711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RESEARCH ON DESFERRIOXAMINE B. II. THE MECHANISM OF FERRO-CHELATION "IN VIVO" BY DESFERRIOXAMINE B].
    VENTURA S; BETTI R; PALUMBO R; SENIN U; CAPPELLETTI M; COLI L
    Haematologica; 1964; 49():181-96. PubMed ID: 14216302
    [No Abstract]   [Full Text] [Related]  

  • 7. [ASIMPLE 6 HOUR TEST WITH INTRAMUSCULAR DESFERRIOXAMINE-B (DESFERAL) FOR THE DIAGNOSIS OF HEMOCHROMATOSIS].
    SCHMID JR; OECHSLIN RJ; SCHNIDER T; MOESCHLIN S
    Schweiz Med Wochenschr; 1964 Nov; 94():1652-5. PubMed ID: 14319645
    [No Abstract]   [Full Text] [Related]  

  • 8. DESFERRIOXAMINE EFFECT ON IRON EXCRETION IN HEMOCHROMATOSIS.
    WALSH JR; MASS RE; SMITH FW; LANGE V
    Arch Intern Med; 1964 Mar; 113():435-41. PubMed ID: 14096399
    [No Abstract]   [Full Text] [Related]  

  • 9. [DESFERRIOXAMINE IN THE DETERMINATION OF THE SIZE OF THE LABILE IRON POOL].
    SCHOLZ A; OEFF K
    Klin Wochenschr; 1963 Dec; 41():1186-8. PubMed ID: 14107273
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE USE OF DESFERRIOXAMINE IN THE TREATMENT OF HEMOCHROMATOSIS].
    CARLOS AG; SOARES AD
    J Med (Oporto); 1964 Apr; 53():1021-32. PubMed ID: 14145895
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES IN THE DEVELOPMENT OF A SCREENING TEST OF IRON STORAGE DISEASE.
    BIEDERMANN P; FITZGERALD JD; KEBERLE H
    Acta Haematol; 1965 May; 33():297-307. PubMed ID: 14314665
    [No Abstract]   [Full Text] [Related]  

  • 12. [RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
    VENTURA S; COLI L
    Haematologica; 1964; 49():252-73. PubMed ID: 14217827
    [No Abstract]   [Full Text] [Related]  

  • 13. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
    WOEHLER F
    Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
    [No Abstract]   [Full Text] [Related]  

  • 14. [HEMOCHROMATOSIS--A CASE TREATED WITH DESFERRIOXAMINE].
    GYLLENSWAERD A; ESTBORN B
    Sven Lakartidn; 1963 Nov; 60():3506-10. PubMed ID: 14096236
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the study of intestinal absorption of inorganic and dietary iron by means of Fe59 in healthy subjects, patients with hemochromatosis and cirrhosis, before and after treatment with Desferal].
    Delaloye B; Magnenat P; Blanc B
    Nucl Med (Stuttg); 1967; ():97-111. PubMed ID: 5601765
    [No Abstract]   [Full Text] [Related]  

  • 16. [EMPLOYMENT OF INJECTABLE DESFERRIOXAMINE B IN IRON LOADING OF HEMOCHROMATOSIS].
    PICHOT J; DORCHE J; PERROT L; VACHON A
    Rev Lyon Med; 1965 Mar; 14():241-8. PubMed ID: 14309517
    [No Abstract]   [Full Text] [Related]  

  • 17. IRON METABOLISM IN SYMPTOMATIC PORPHYRIA. A PRELIMINARY COMMUNICATION.
    SAUNDERS SJ
    S Afr J Lab Clin Med; 1963 Dec; 14():277-82. PubMed ID: 14110525
    [No Abstract]   [Full Text] [Related]  

  • 18. THE VALUE OF DESFERRIOXAMINE AS A DIAGNOSTIC TEST IN IRON OVERLOAD.
    PAWELSKI S; TOPOLSKA P; ROSZKOWSKI S; RADECKA K
    Pol Med Sci Hist Bull; 1965 Apr; 8():69-71. PubMed ID: 14319221
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE EFFECT OF PHOSPHORUS AND CALCIUM SALTS AND IRON-POOR DIET OR IRON-FREE NUTRITION ON THE IRON EXCRETION BALANCE OF PATIENTS WITH HEMOCHROMATOSIS RECEIVING DESFERRIOXAMINE THERAPY].
    TEUBNER K; WEISE HJ
    Verh Dtsch Ges Inn Med; 1964; 70():404-6. PubMed ID: 14294251
    [No Abstract]   [Full Text] [Related]  

  • 20. IRON-59 ABSORPTION MEASUREMENTS BY WHOLE-BODY COUNTING: STUDIES IN ALCOHOLIC CIRRHOSIS, HEMOCHROMATOSIS, AND PANCREATITIS.
    DELLER DJ
    Am J Dig Dis; 1965 Mar; 10():249-58. PubMed ID: 14263062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.